<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="889">
  <stage>Registered</stage>
  <submitdate>18/11/2005</submitdate>
  <approvaldate>24/11/2005</approvaldate>
  <actrnumber>ACTRN12605000763640</actrnumber>
  <trial_identification>
    <studytitle>Effect of remifentanil on electroencephalographic BAR index during propofol anaesthesia</studytitle>
    <scientifictitle>A randomised study to evaluate the effects of remifentanil on the monitoring of anaesthetic depth with the BAR index or BIS during propofol anaesthesia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Anaesthetic depth and EEG changes</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Remifentanil effect-site target 2 or 4 ng/ml during induction of anaesthesia with propofol</interventions>
    <comparator>Remifentanil effect-site target 0 (control) ng/ml during induction of anaesthesia with propofol</comparator>
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Depth of anaesthesia (loss of eyelash reflex, response to command or painful stimulation) during induction of anaesthesia</outcome>
      <timepoint>Assessed every 5 minutes during slow induction of anaesthesia with propofol until loss of response to painful stimulation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Propofol concentrations and EEG measures preventing 50% of patients from responding during induction of anaesthesia.</outcome>
      <timepoint>Assessed every 5 minutes during slow induction of anaesthesia with propofol until loss of response to painful stimulation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA physical status 1-3 presenting for elective surgery under GA.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria> Patients with EEG abnormalities will not be included.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed envelopes</concealment>
    <sequence>computer generated</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>6/02/2006</anticipatedstartdate>
    <actualstartdate>12/09/2006</actualstartdate>
    <anticipatedenddate />
    <actualenddate>10/09/2007</actualenddate>
    <samplesize>45</samplesize>
    <actualsamplesize>55</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress>Royal Melbourne Hospital, Parkville, Victoria, 3050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Biopharmica Limited</fundingname>
      <fundingaddress>1 Dalmore Drive, Scoresby, VIC, 3179</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>Biopharmica Limited</sponsorname>
      <sponsoraddress>1 Dalmore Drive, Scoresby, VIC, 3179</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>These data were not published because the quality of the EEG data was very poor. This was due to equipment malfunction.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Melbourne Health HREC</ethicname>
      <ethicaddress>Royal Melbourne Hospital
Parkville VIC 3050</ethicaddress>
      <ethicapprovaldate>7/08/2008</ethicapprovaldate>
      <hrec>Nil known</hrec>
      <ethicsubmitdate>22/07/2008</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Associate Professor Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050</address>
      <phone>+61 3 93427000</phone>
      <fax />
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Associate Professor Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050</address>
      <phone>+61 3 93427000</phone>
      <fax />
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management Royal Melbourne Hospital Parkville VIC 3050</address>
      <phone>+ 61 3 93427540</phone>
      <fax>+61 3 93428623</fax>
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Kate Leslie</name>
      <address>Department of Anaesthesia and Pain Management
Royal Melbourne Hospital
Parkville VIC 3050
Australia
</address>
      <phone>+61-3-93427540</phone>
      <fax />
      <email>kate.leslie@mh.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>